VaramirStart free · no cardSign in
IMVT as of Oct 31 · 22:53 ET
IMVTNasdaqBiological Products, (No Diagnostic Substances)

Immunovant, Inc. · Brief

Next report

8 days

Nov 9 · before openest.Q2 FY27
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±13.7%
avg realized
±9.2%
Nov 7 '24±8.5%▼−4.74%×0.56
Feb 6 '25±16.5%▼−9.55%×0.58
May 29 '25±16.1%▲+5.60%×0.35
Aug 11 '25±13.9%▼−4.53%×0.32
Nov 10 '25±16.2%▲+0.09%×0.01
Q3 FY26±13.5%▲+12.43%×0.92
May 20 '26±15.6%▲+35.26%×2.26
Q1 FY27±9.0%▲+1.17%×0.13
quarterimplied−40%0+40%realized×
Q1 FY27±9.0%▲+1.17%×0.13
May '26±15.6%▲+35.26%×2.26
Q3 FY26±13.5%▲+12.43%×0.92
Nov '25±16.2%▲+0.09%×0.01
Aug '25±13.9%▼−4.53%×0.32
May '25±16.1%▲+5.60%×0.35
2 older reports
Feb '25±16.5%▼−9.55%×0.58
Nov '24±8.5%▼−4.74%×0.56
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

227managers reporting a position in the latest quarterly filings13F · Jun 30 '26
20managers whose positions together make up four fifths of reported value13F · Jun 30 '26

Bear2

5tracked funds holding IMVTN-PORT · Aug 31 '26
10 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IMVT report session

Suppliers 1

ROIVRoivant Sciences×0.43
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±13.9% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.